CN202516157U - Output device of ultrasonic intermediate frequency drug guiding instrument - Google Patents
Output device of ultrasonic intermediate frequency drug guiding instrument Download PDFInfo
- Publication number
- CN202516157U CN202516157U CN2012201179814U CN201220117981U CN202516157U CN 202516157 U CN202516157 U CN 202516157U CN 2012201179814 U CN2012201179814 U CN 2012201179814U CN 201220117981 U CN201220117981 U CN 201220117981U CN 202516157 U CN202516157 U CN 202516157U
- Authority
- CN
- China
- Prior art keywords
- intermediate frequency
- ultrasonic
- output device
- medicine
- guiding instrument
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Landscapes
- Electrotherapy Devices (AREA)
Abstract
The utility model relates to the field of medical equipment, in particular to an output device of an ultrasonic intermediate frequency drug guiding instrument, and solves the problems of poor matching between a transdermal drug delivery patch and a treatment head of the ultrasonic intermediate frequency drug guiding instrument, poor treatment effect, insufficiently tight contact with the skin and the like of the ultrasonic intermediate frequency drug guiding instrument. The output device of the ultrasonic intermediate frequency drug guiding instrument is provided with an electrode connection plate, a positioning ring and a drug filling ring; the positioning ring and the drug filling ring are respectively arranged on both sides of the electrode connection plate; the positioning ring is buckled with the treatment head of the ultrasonic intermediate frequency drug guiding instrument; the electrode connection plate is contacted and connected with the outer surface of a treatment electrode and is accurately positioned; the output device is in close fit with the treatment head of the ultrasonic intermediate frequency drug guiding instrument, so that the treatment electrode in the treatment head of the ultrasonic intermediate frequency drug guiding instrument is tightly contacted and connected with the electrode connection plate; the electrical conductivity is strong; and the treatment effect is better.
Description
Technical field
This utility model relates to field of medical, is specially the output device that a kind of Ultrasonic-intermediate Frequency is led the medicine appearance.
Background technology
It is through the cavitation of ultrasound wave generation and the electroporation and the iontophoresis effect stack of direct current or pulse current that Ultrasonic-intermediate Frequency is led the medicine appearance, impels drug particle to see through skin or mucosa, gets into local organization, reaches the purpose of Drug therapy.The treatment head that Ultrasonic-intermediate Frequency is led the medicine appearance is hyperacoustic generation, emission and contacts the back with body and form current loop, and the device that is connected with main frame through lead.
Ultrasonic-intermediate Frequency is led the percutaneous dosing paster that the medicine appearance uses, and can get into human circulation through intact skin by controlled release drug, the effect of performance Drug therapy.At present, existing paster is formed through sticking or compacting by backing layer, medicine storing layer, absorption pad, pressure sensitive adhesive in certain sequence, and backing layer plays the support effect, and medicine storing layer, absorption pad are relied on it, is processed by impermeable material.Medicine storing layer is made up of medicine and substrate, plays medicine storage, controlled-release function.Absorption pad is used for absorbing the moisture content that use occurs, and pressure-sensitive adhesive is affixed on human body skin.
In the past, Ultrasonic-intermediate Frequency was led the medicine appearance when using, and it is bad to exist the treatment head to cooperate with dosing paster, during actual clinical during the treatment application, had relatively poor, and the problem such as contact skin defective tightness of therapeutic effect.
The utility model content
The purpose of this utility model is to provide a kind of Ultrasonic-intermediate Frequency to lead the output device of medicine appearance, solve percutaneous dosing paster that Ultrasonic-intermediate Frequency leads the medicine appearance and Ultrasonic-intermediate Frequency lead medicine appearance treatment head cooperate bad, therapeutic effect is relatively poor, and problem such as contact skin defective tightness.
The technical scheme of this utility model is:
A kind of Ultrasonic-intermediate Frequency is led the output device of medicine appearance, and this output device is provided with electrode contact, locating ring and powder charge ring, and the both sides of electrode contact are provided with locating ring and powder charge ring respectively.
Described Ultrasonic-intermediate Frequency is led the output device of medicine appearance, and the treatment head that locating ring and Ultrasonic-intermediate Frequency are led the medicine appearance fastens.
Described Ultrasonic-intermediate Frequency is led the output device of medicine appearance, and locating ring is fastened on the treatment head outside that Ultrasonic-intermediate Frequency is led the medicine appearance.
Described Ultrasonic-intermediate Frequency is led the output device of medicine appearance, and electrode contact is connected with the therapeutic electrode outer surface contact that Ultrasonic-intermediate Frequency is led the medicine appearance.
Described Ultrasonic-intermediate Frequency is led the output device of medicine appearance, and the therapeutic electrode end is located at Ultrasonic-intermediate Frequency through the extension dividing potential drop and is led in the treatment head of medicine appearance, and the outer surface of therapeutic electrode protrudes in the surface of treatment head.
Described Ultrasonic-intermediate Frequency is led the output device of medicine appearance, is equiped with medicine layer in the powder charge ring, and medicine layer is connected with the contact of electrode contact surface.
The beneficial effect of this utility model is:
1, this utility model Ultrasonic-intermediate Frequency output device of leading the medicine appearance is provided with electrode contact, locating ring and powder charge ring, and the both sides of electrode contact are provided with locating ring and powder charge ring respectively.The outer surface that Ultrasonic-intermediate Frequency is led the therapeutic electrode of medicine appearance protrudes in the surface of treating head; Locating ring fastens with the treatment head; The contact of electrode contact and therapeutic electrode outer surface is connected, accurate positioning, output device and Ultrasonic-intermediate Frequency lead medicine appearance treatment head cooperates tight, make Ultrasonic-intermediate Frequency lead the medicine appearance treat in therapeutic electrode closely contact with electrode contact and be connected; Electric conductivity is strong, and therapeutic effect is better.
2, in this utility model, medicine layer is installed in the powder charge ring, and medicine layer is connected with the contact of electrode contact surface, and medicine layer protrudes in the powder charge ring outer surface, and is tightr with contact skin.
Description of drawings
Fig. 1 leads the output device structural representation of medicine appearance for this utility model Ultrasonic-intermediate Frequency.
Fig. 2 leads the structural representation of medicine appearance for the Ultrasonic-intermediate Frequency that adopts this utility model.
Among the figure, 1 treatment head; 2 therapeutic electrodes (steel disc); 21 extensions; 3 medicine layers; 4 electrode contacts; 5 locating rings; 6 powder charge rings.
The specific embodiment
As shown in Figure 1, the output device that this utility model Ultrasonic-intermediate Frequency is led the medicine appearance mainly comprises: electrode contact 4, locating ring 5 and powder charge ring 6, the both sides of electrode contact 4 are provided with locating ring 5 and powder charge ring 6 respectively.
As shown in Figure 2; Adopting the Ultrasonic-intermediate Frequency of this utility model to lead the medicine appearance mainly comprises: treatment 1, therapeutic electrode 2, medicine layer 3, electrode contact 4, locating ring 5, powder charge ring 6 etc.; The outer surface of therapeutic electrode 2 protrudes in the surface of treatment 1; The both sides of electrode contact 4 are provided with locating ring 5 and powder charge ring 6 respectively; Locating ring 5 and treatment 1 fastens, and electrode contact 4 is connected with the contact of therapeutic electrode 2 outer surfaces, and therapeutic electrode 2 ends are located at Ultrasonic-intermediate Frequency through extension 21 pressures and are led in the treatment 1 of medicine appearance.Medicine layer 3 is installed in the powder charge ring 6, and medicine layer 3 is connected with electrode contact 4 surface contacts.
In this utility model, medicine layer 3 protrudes in powder charge ring 6 outer surfaces, and is tightr with contact skin.
In this utility model, locating ring 5 is fastened on the outside of treatment 1, cooperates tight with the treatment head.
During work; Therapeutic electrode 2 can be connected to direct current or impulse current generator through lead; Treatment 1 an interior ultrasonic transducer wafer that is provided with can be connected to supersonic generator through lead; Realized that ultrasound wave and electron ion import promotion transdermal administration superposition, made drug molecule and particle get into human body rapidly, reached the purpose of treatment.
Claims (6)
1. a Ultrasonic-intermediate Frequency is led the output device of medicine appearance, and it is characterized in that: this output device is provided with electrode contact, locating ring and powder charge ring, and the both sides of electrode contact are provided with locating ring and powder charge ring respectively.
2. lead the output device of medicine appearance according to the described Ultrasonic-intermediate Frequency of claim 1, it is characterized in that: the treatment head that locating ring and Ultrasonic-intermediate Frequency are led the medicine appearance fastens.
3. lead the output device of medicine appearance according to the described Ultrasonic-intermediate Frequency of claim 1, it is characterized in that: locating ring is fastened on the treatment head outside that Ultrasonic-intermediate Frequency is led the medicine appearance.
4. lead the output device of medicine appearance according to the described Ultrasonic-intermediate Frequency of claim 1, it is characterized in that: electrode contact is connected with the therapeutic electrode outer surface contact that Ultrasonic-intermediate Frequency is led the medicine appearance.
5. lead the output device of medicine appearance according to the described Ultrasonic-intermediate Frequency of claim 4, it is characterized in that: the therapeutic electrode end is located at Ultrasonic-intermediate Frequency through the extension dividing potential drop and is led in the treatment head of medicine appearance, and the outer surface of therapeutic electrode protrudes in the surface of treatment head.
6. lead the output device of medicine appearance according to the described Ultrasonic-intermediate Frequency of claim 1, it is characterized in that: be equiped with medicine layer in the powder charge ring, medicine layer is connected with the contact of electrode contact surface.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012201179814U CN202516157U (en) | 2012-03-27 | 2012-03-27 | Output device of ultrasonic intermediate frequency drug guiding instrument |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012201179814U CN202516157U (en) | 2012-03-27 | 2012-03-27 | Output device of ultrasonic intermediate frequency drug guiding instrument |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN202516157U true CN202516157U (en) | 2012-11-07 |
Family
ID=47099130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012201179814U Expired - Lifetime CN202516157U (en) | 2012-03-27 | 2012-03-27 | Output device of ultrasonic intermediate frequency drug guiding instrument |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN202516157U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108744259A (en) * | 2018-06-19 | 2018-11-06 | 南京奥珂森电子有限公司 | Ultrasonic conductance fixes patch |
-
2012
- 2012-03-27 CN CN2012201179814U patent/CN202516157U/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108744259A (en) * | 2018-06-19 | 2018-11-06 | 南京奥珂森电子有限公司 | Ultrasonic conductance fixes patch |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN203154602U (en) | Skin positioning transdermal delivery device assisted by ultrasonic wave, laser and electric field | |
| AU2002363106B2 (en) | Device and method for controlled delivery of active substance into the skin | |
| US20020156414A1 (en) | Ultrasonically enhanced substance delivery method | |
| US20180325836A1 (en) | Ultrasonic transducers suitable for ultrasonic drug delivery via a system, which is portable and wearable by the patient | |
| CN104436451B (en) | A kind of human body patch of mating therapeutic equipment | |
| JP2011519638A (en) | Method and apparatus for promoting transdermal diffusion | |
| US20100228180A1 (en) | Power Source Electrode Treatment Device | |
| CN202516157U (en) | Output device of ultrasonic intermediate frequency drug guiding instrument | |
| CN201658751U (en) | Electrode paster used for transdermal drug delivery | |
| CN204335849U (en) | For the siRNA cutaneous penetration brassiere of mastocarcinoma gene treatment | |
| CN201423082Y (en) | Long-acting ion introduction patch convenient for storing and carrying | |
| CN104740757A (en) | Ultrasonic and iontophoresis combined transdermal drug delivery device | |
| CN216497084U (en) | Electrode patch for ultrasonic physiotherapy | |
| CN213884731U (en) | Electrode paster with aluminum foil layer structure | |
| CN205073512U (en) | Take supersound conductivity meter of magnetism physiotherapy electrode | |
| CN201253417Y (en) | Skin electrode with residence physical therapy plaster | |
| CN203075468U (en) | Hydraulic conductive rubber electrode plate | |
| CN109481422B (en) | Graphene oxide electrothermal film transdermal patch | |
| CN2621668Y (en) | Instant magnetic medicinal plaster | |
| CN203108002U (en) | Disposable drug import patch | |
| CN201350285Y (en) | Indolence preparation skin injection device | |
| CN207950336U (en) | A kind of magnetic connects flexibility physiogherapy electrode plate and electrode sheet devices | |
| CN201064622Y (en) | Ion leading-in medicine label convenient for storing and carrying | |
| CN217593600U (en) | Enhanced ultrasonic coupling electrode patch | |
| CN213312915U (en) | Novel ultrasonic therapy fixing patch |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170703 Address after: 110000 Liaoning Province, Shenyang City District Hunhe Street No. 26 Patentee after: Shenyang Midea Medical Instrument Co., Ltd. Address before: Hongfa international 15A-06 47-2 Shen Liaodong road in Tiexi District of Shenyang City, Liaoning province 110023 Patentee before: Du Nan |
|
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20121107 |